SIRIS BIOFOTONTERAPI AS

Signals

2 flags

• ▼ Negativ egenkapital 2024 Bokført egenkapital er negativ (−302k kr).
• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−36k kr).

SIRIS BIOFOTONTERAPI AS is registered as a limited company in Lillehammer, Innlandet with organisation number 911943212. The business is classified under other health services (NACE 86.993). The company was incorporated in 2013. Registered share capital is NOK 30,000, divided into 30 shares. The company's stated purpose is: “Tilby biofotonterapi samt annen virksomhet forbundet med dette, herunder å eie aksjer i andre selskaper.”. The most recent filed accounts, for the 2024 financial year, show NOK 679,000 in revenue and NOK −36,000 in operating profit.

Key figures · 2024

Revenue

NOK 679,000

Operating profit

NOK −36,000

Equity

NOK −302,000

Financial health · 2024

Liquidity

0.59

Weak

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

-69.4%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns SIRIS BIOFOTONTERAPI AS?

SIRI KLUFTEN

100.0%

SIRIS BIOFOTONTERAPI AS

NOK 679,000 rev. · NOK −36,000 profit

SIRIS BIOFOTONTERAPI AS has 1 registered shareholder:

• SIRI KLUFTEN 100.0%

All shareholders and roles →

Frequently asked questions about SIRIS BIOFOTONTERAPI AS

Who owns SIRIS BIOFOTONTERAPI AS?

SIRI KLUFTEN is the largest registered owner, with 100.0%.

What is the revenue of SIRIS BIOFOTONTERAPI AS?

SIRIS BIOFOTONTERAPI AS had revenue of NOK 679,000 in 2024.

Who is the general manager of SIRIS BIOFOTONTERAPI AS?

Siri Kluften is registered as general manager of SIRIS BIOFOTONTERAPI AS.

Where is SIRIS BIOFOTONTERAPI AS based?

SIRIS BIOFOTONTERAPI AS has its business address in Lillehammer.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.